Cellectis (CLLS)
(Delayed Data from NSDQ)
$2.65 USD
-0.02 (-0.75%)
Updated Mar 28, 2024 03:59 PM ET
After-Market: $2.65 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
04/03/2024
Time: -- |
12/2023 | $-0.48 | 0.00% |
Earnings Summary
For their last quarter, Cellectis (CLLS) reported earnings of -$0.31 per share, beating the Zacks Consensus Estimate of $-0.36 per share. This reflects a positive earnings surprise of 13.89%. Look out for CLLS's next earnings release expected on April 03, 2024. For the next earning release, we expect the company to report earnings of -$0.48 per share, reflecting a year-over-year increase of 15.79%.
Earnings History
Price & Consensus
Zacks News for CLLS
Iovance (IOVA) Doses First Patient in TIL Cancer Therapy Study
CLLS: What are Zacks experts saying now?
Zacks Private Portfolio Services